Together, these observations argue for an active role of the TME in modulating g1 ILC mediated anti-tumor responses, where TGF-β producing tumors convert NK cells into less cytotoxic ILC1s with impaired anti-tumor functions. The gene discussed is TGFB1; the disease is neoplasm.